The vast amounts of data and complex genetic information generated by Next Generation Sequencing (NGS) are changing the way we care and make treatment decisions. Next Generation Sequencing methods can now be used to analyze disease risk, drug metabolism status, whole oncogene analysis, whole exome gene sequencing analysis, and provide reference for immunotherapy and cell therapy decision-making.

While moving towards the goal of precision medicine, the detection platform, reagent technology and information analysis in this field are constantly being improved and updated; new knowledge is also produced in disease research and clinical interpretation and interpretation.

The main members of the company are from the Cancer Progress Research Center of National Yangming Jiaotong University. It is the first Genome Center established in Taiwan who has independent sequencing, microarray and bioinformatics teams. Based on accumulated rich experience, Cubic Station is proposed as a solution to optimize gene body analysis.

Cubic Genomics integrates software and hardware vehicles and proposes Cubic Station, which accelerates analysis speed through a standardized system, reduces the burden on analysts, and greatly reduces the entry threshold for analysts through an intuitive graphical operation interface, which is helpful for talent recruitment. The graphical operation interface simultaneously Can improve the first-line clinical use of genomics.